Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Genitourinary Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Genitourinary Other
    Combination Treatment May Help Patients With Peyronie's Disease: Presented at ESSM - (DGDispatch)
    Dynamic MRI Identifies Women With Pelvic Organ Prolapse - (DGNews)
    Propagation of Human Spermatogonial Stem Cells In Vitro - (JAMA)
    Verapamil Injection Eases Pain of Peyronie's Disease: Presented at ESSM - (DGDispatch)
    Patients Prefer Daily Paroxetine for Premature Ejaculation: Presented at ESSM - (DGDispatch)

    News archive

     Recent webcasts/CME - Genitourinary Other
    • Early and Aggressive Management of Treatment-Related Adverse Effects Is Essential for Achieving Optimal Clinical Outcome With Targeted Therapies in Patients With Kidney Cancer
    • Reducing the Burden of Overactive Bladder: A Global Perspective
    • Primary Care Update in Urology
      Urinalysis: A Guide for Pharmacists
      The Treatment of Benign Prostatic Hyperplasia

      Webcasts/CME archive

       Recent cases - Genitourinary Other
        Increased Frequency and Nocturia in a Middle Aged Male May Not Always Be Due to Benign Prostatic Hypertrophy (BPH): A Case Report
        Localized Amyloidosis Presenting with a Penile Mass: A Case Report
        Fetal Bone as a Foreign Body in the Urinary Bladder: A Case Report
        Mycobacterium Avium-Intracellulare Infection Presenting as a Testicular Mass in an Immunocompromised Patient: A Case Report
        Duplex Cryptorchid Testis Presenting as a Strangulated Hernia: A Case Report

        Cases archive
          




        my personal edition > genitourinary other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Lemonade, Potassium Citrate Effective in Reducing Kidney Stone Risk: Presented at AUA

        By Ed Susman

        ATLANTA, G.A. -- May 26, 2006 -- Lemonade therapy and prescription potassium citrate both increase urinary citrate to levels that protect against kidney stone formation, doctors reported here at the American Urological Association 101st Annual Meeting.

        "Lemonade therapy appears to have the potential to prevent kidney stones," said Marshall Stoller, MD, professor and vice chairman of urology, University of California, San Francisco, California, who moderated a press briefing at which the research was presented.

        Study presenter David Kang, 4th year medical school student, Duke University Medical Center, Durham, North Carolina, and colleagues compared the urine environment of patients on a lemonade therapy regimen to patients taking potassium citrate.

        Kang enrolled 5 men and 7 women in each study arm and measured pre- and post-treatment total volume of urine output and acidity, and levels of calcium, citrate, oxalate, uric acid and sodium. By x-ray and computer-assisted tomography, the stone burden and stone formation rate was also measured.

        Eleven of the patients in the 12 lemonade arm improved their urinary citrate levels, changing the level by 354 mg, a difference that was statistically significant from baseline (P <.05). All 12 potassium citrate patients improved their urinary citrate levels an average of 472 mg (P <.05), the difference between the groups was also statistically significant at the P <.05 level.

        "Potassium citrate is the preferred treatment for hypocitraturic calcium stone formers," Kang said. However, he acknowledged that lemonade is a good alternative if the patient can't handle the potassium citrate tablets due to adverse effects or cost.

        Dr. Stoller noted that, for both products, the level of urinary citrate was well above 600 mg, considered a goal for preventing stone formation.

        Kang said that neither group proved that lemonade actually lessened the incidence of clinical stone cases. However, Dr. Stoller said that a larger, long-term study -- advocated by the researchers -- would be likely to show that increasing urinary citrate in these patients would later prove clinical beneficial for prevention of stone formation.

        Dr. Stoller said the studies give patients a choice of either the prescription medicine that can be taken in tablets or crystals, or the lemonade.


        [Presentation title: Lemonade-Based Dietary Manipulation in Patients With Hypocitraturic Nephrolithiasis. Abstract 1038]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send